Shanghai Pharmaceuticals Holding Co., Ltd
Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY) Revenue
Annual & quarterly revenue history · segment & region breakdown
SHPMY · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsShanghai Pharmaceuticals Holding Co., Ltd trailing twelve-month (TTM) revenue is $288B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
Medical - DistributionCompare SHPMY revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Shanghai Pharmaceuticals Holding Co., Ltd receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Shanghai Pharmaceuticals Holding Co., Ltd reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Shanghai Pharmaceuticals Holding Co., Ltd's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
SHPMY revenue · 4 questionsSHPMY's trailing twelve-month (TTM) revenue is $288B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Shanghai Pharmaceuticals Holding Co., Ltd SEC filings · GAAP · Shanghai Pharmaceuticals Holding Co., Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026